KRYS

KRYSTAL BIOTECH, INC.

KRYS · CIK 1711279 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$389M
20172025
Net Income$205M
20172025
Operating CF$201M
20172025
Free Cash Flow$189M
20172025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕
Revenue$0.4B$0.3B$0.1B————
Cost of Revenue———————
Gross Profit———————
R&D Expense$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense$0.1B$0.1B—————
Operating Income$0.2B$0.1B$-0.1B$-0.1B$-0.0B$-0.0B$-0.0B
Net Income$0.2B$0.1B$0.0B$-0.1B$-0.0B$-0.0B$-0.0B
EPS (Basic)$7.08$3.12$0.40$-5.49———
EPS (Diluted)$6.84$3.00$0.39$-5.49———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕
Total Assets$1.3B$1.1B$0.8B$0.6B$0.3B$0.2B$0.1B
Current Assets$1.0B$0.7B$0.6B$0.4B$0.3B$0.2B$0.0B
Cash & Equivalents$0.5B$0.3B$0.4B$0.2B$0.3B$0.2B$0.0B
Total Liabilities$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$1.2B$0.9B$0.8B$0.5B$0.3B$0.2B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕
Operating Cash Flow$0.2B$0.1B$-0.1B$-0.1B$-0.0B$-0.0B—
Investing Cash Flow$-0.1B$-0.2B$0.1B$-0.1B$-0.0B$-0.0B—
Capital Expenditures$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$0.2B$0.0B$0.1B$0.1B—
← Companies